Medicare beneficiaries 65 years and older who participated in five to six weeks of cognitive speed training with follow-up sessions three years later were less likely to be diagnosed with Alzheimer's ...

The findings suggest that when alpha-synuclein -- a protein associated with Parkinson's and other Lewy body diseases -- accumulates alongside Alzheimer's pathology, it may drive faster Alzheimer's ...

Alzheimer's-related brain changes progressed up to 20 times faster in women who also had abnormal levels of a ...

For over thirty years, researchers have primarily studied the accumulation of amyloid beta proteins in the brains of Alzheimer’s patients. They also focus on how that component negatively impacts ...

Hope for Alzheimer's prevention emerges as scientists find existing seizure drug may stop disease progression if taken ...

Each monthly installment examines an aspect of Alzheimer's disease care, including making and delivering the diagnosis; ...

New paper from UC Santa Cruz chemistry lab argues that efforts to develop treatments for Alzheimer's should stop ignoring a ...

Two new clinical trials aimed at treating Alzheimer’s disease are starting up at Barrow Neurological Institute.

Researchers have identified a new type of blood-based biomarker test for Alzheimer's disease that measures structural changes in proteins, providing more information on the underlying biology of the ...

Summary: Women make up nearly two-thirds of Alzheimer’s patients, and researcher may have just discovered a massive reason why. A new study found that when the protein alpha-synuclein (typically ...

Researchers have developed a diagnostic panel that identifies cognitive decline by analyzing how blood proteins fold. This ...

Wednesday saw a record turnout -- with a State House security guard reporting over 1,400 people making their way inside ...